A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard peri-operative care in women with residual triple negative early stage/resectable breast cancer after standard-of-care neoadjuvant chemotherapy Meeting Abstract


Authors: McArthur, H. L.; Comen, E. A.; Solomon, S.; Rodine, M.; DiLauro Abaya, C.; Leal, J. H. S.; Patil, S.; Norton, L.
Abstract Title: A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard peri-operative care in women with residual triple negative early stage/resectable breast cancer after standard-of-care neoadjuvant chemotherapy
Meeting Title: 41st Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 79
Issue: 4 Suppl.
Meeting Dates: 2018 Dec 4-10
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2019-02-01
Language: English
ACCESSION: WOS:000478677000139
DOI: 10.1158/1538-7445.Sabcs18-ot2-06-05
PROVIDER: wos
Notes: Meeting Abstract: OT2-06-05 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil
  2. Larry Norton
    758 Norton
  3. Elizabeth Comen
    72 Comen
  4. Stephen Solomon
    422 Solomon
  5. Micaela Ariel Henrich
    11 Henrich